DDIT3 and cancer: Tumor‐infiltrating MDSCs exhibit higher expression levels of CHOP compared to splenic MDSCs from mouse cancer models; this increased expression facilitates the accumulation of MDSCs and enhances their ability to suppress T cell activity by upregulating IL‐6 and arginase expression [106].